Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Exact Sciences raises $178.5M in follow-on

    Exact Sciences Corp. (NASDAQ:EXAS) raised $178.5 million through the sale of 7 million shares at $25.50 in a follow-on underwritten by Jefferies and Baird. The company proposed the offering after market close Monday, …

    Published on 7/21/2015
  • FINANCIAL NEWS: Oxford Nanopore raises L70M

    Oxford Nanopore Technologies Ltd. (Oxford, U.K.) raised L70M ($109.2 million) in a private placement with undisclosed new and existing investors in the U.K., U.S. and Europe. The company develops and markets nanopore-…

    Published on 7/21/2015
  • FINANCIAL NEWS: Athyrium, Neuberger close $1.2B fund

    Athyrium Capital Management and partner Neuberger Berman closed a $1.2 billion fund that will invest in commercial stage healthcare companies. The fund, Athyrium Opportunities Fund II, plans to make about 20 investments…

    Published on 7/20/2015
  • FINANCIAL NEWS: Financial tracks

    Investment firm Water Street Healthcare Partners named Paul Cottey chief information officer. Cottey was EVP and CIO at PatientMatters LLC.

    Published on 7/17/2015
  • FINANCIAL NEWS: RedHill, Trovagene price follow-ons

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL) raised $40 million on Friday through the sale of 2.5 million ADSs at $16.25 in an offering underwritten by Nomura; Roth Capital Partners; MLV; and H.C. Wainwright. …

    Published on 7/17/2015
  • FINANCIAL NEWS: Shandong Luoxin invests $10M in WuXi fund

    Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (HKSE:8058) committed to invest $10 million in WuXi Healthcare Ventures Fund II through its Luoxin Hong Kong Holdings Ltd. subsidiary.The WuXi fund plans to raise $250…

    Published on 7/17/2015
  • FINANCIAL NEWS: Chiasma gains after upsized IPO

    Chiasma Inc. (NASDAQ:CHMA) gained $4 (25%) to $20 in its first day of trading Thursday after it raised $101.8 million through the sale of 6.4 million shares at $16 in an IPO underwritten by Barclays; Cowen; William …

    Published on 7/16/2015
  • FINANCIAL NEWS: Follow-ons: Ultragenyx, NeuroDerm, Synthetic Biologics

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), NeuroDerm Ltd. (NASDAQ:NDRM) and Synthetic Biologics Inc. (NYSE-M:SYN) raised a combined $370.9 million in follow-on offerings on Thursday.Ultragenyx raised $264 million …

    Published on 7/16/2015
  • FINANCIAL NEWS: Piqur raises CHF18M in series A extension

    Piqur Therapeutics AG (Basel, Switzerland) raised CHF18 million ($19 million) in a second extension of its series A round from new and existing investors. Prior investor Versant Ventures was among the investors; it led …

    Published on 7/16/2015
  • FINANCIAL NEWS: ProNAi rises following $137.7M IPO

    ProNAi Therapeutics Inc. (NASDAQ:DNAI) jumped $13.30 (81%) to $30.80 in its first day of trading Thursday after raising $137.7 million through the sale of 8.1 million shares at $17 in an IPO. The price valued the …

    Published on 7/16/2015
  • FINANCIAL NEWS: Protagonist raises $40M in series C

    Protagonist Therapeutics Inc. (Milpitas, Calif.) raised $40 million in a series C round led by Canaan Partners. New investors Adage Capital Management; RA Capital; and Foresite Capital also participated, as did existing…

    Published on 7/16/2015
  • FINANCIAL NEWS: AnaptysBio raises $40M in series D

    Antibody play AnaptysBio Inc. (San Diego, Calif.) raised $40 million in an oversubscribed series D round. BVF Partners and its affiliates; Cormorant Asset Management; Frazier Healthcare; HBM Healthcare Investments; …

    Published on 7/15/2015
  • FINANCIAL NEWS: DBV, MacroGenics price follow-ons

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) and MacroGenics Inc. (NASDAQ:MGNX) raised a combined $375.2 million in follow-on offerings.DBV raised $244.8 million through the sale of 7.2 million ADSs at $34 in an …

    Published on 7/15/2015
  • FINANCIAL NEWS: Arivale raises $36M in series B

    Arivale Inc. (Seattle, Wash.) raised $36 million in a series B round led by Arch Venture Partners and Polaris Partners. Maveron, which led the company's $3 million series A round in January 2014, also participated. …

    Published on 7/14/2015
  • FINANCIAL NEWS: J&J talks "disciplined" M&A

    Multiple analysts pressed Johnson & Johnson (NYSE:JNJ) about the pharma's M&A strategy during Tuesday's 2Q15 earnings call. "We do feel that there are several significant opportunities, really across each one of our …

    Published on 7/14/2015
  • FINANCIAL NEWS: WuXi fund to raise $250M

    WuXi Healthcare Ventures Fund II plans to raise $250 million, according to an SEC filing. The fund will invest in healthcare companies in the U.S. and China. Wei Li is listed as the fund's general partner director. In …

    Published on 7/14/2015
  • FINANCIAL NEWS: Financial tracks

    Jay Venkatesan joined Alpine BioVentures as a managing partner. Venkatesan was EVP and general manager at Oncothyreon Inc. (NASDAQ:ONTY).

    Published on 7/13/2015
  • FINANCIAL NEWS: LPs go after Burrill

    Burrill Life Sciences Capital Fund III L.P. filed a lawsuit alleging that G. Steven Burrill, Burrill & Co. and members of the firm's management team embezzled more than $17 million from Fund III between 2007 and 2013. …

    Published on 7/13/2015
  • FINANCIAL NEWS: Nuvelution debuts with funding from Clarus, Novo A/S

    Nuvelution Pharma Inc. (San Francisco, Calif.) debuted on Monday with an undisclosed investment from Clarus Ventures and Novo A/S (Hellerup, Denmark). Nuvelution plans to form risk-sharing partnership with biotech and …

    Published on 7/13/2015
  • FINANCIAL NEWS: Financial tracks

    H.C. Wainwright hired Ed Arce as a managing director in equity research. Arce was a senior research analyst in biopharmaceuticals and specialty pharmaceuticals at Roth Capital Partners.

    Published on 7/10/2015
  • FINANCIAL NEWS: Funding round-up: Atara, TherapeuticsMD, ReNeuron

    Atara Biotherapeutics Inc. (NASDAQ:ATRA) and TherapeuticsMD Inc. (NYSE-M:TXMD) raised a combined $210 million in follow-on offerings, while ReNeuron Group plc (LSE:RENE) raised L68.4 million ($106.5 million) in a …

    Published on 7/10/2015
  • FINANCIAL NEWS: 4SC raises EUR 29M

    4SC AG (Xetra:VSC) raised EUR 29 million ($32.1 million) through the sale of 7.3 million shares at EUR 4 in a rights issue with existing shareholders and a private placement with new investors. Existing shareholder …

    Published on 7/9/2015
  • FINANCIAL NEWS: Clovis raises $275M in follow-on

    Clovis Oncology Inc. (NASDAQ:CLVS) raised $275 million through the sale of 3.5 million shares at $78 in a follow-on underwritten by JPMorgan; Credit Suisse; Stifel; and Mizuho Securities. Clovis proposed the offering …

    Published on 7/9/2015
  • FINANCIAL NEWS: Karolinska Development reassesses portfolio value

    Karolinska Development AB (SSE:KDEV) reduced the reported value of its portfolio to SEK679 million ($80.1 million) in 2Q15 from SEK1.4 billion ($165.1 million) in 1Q15 after it changed its method of valuing early stage …

    Published on 7/9/2015
  • FINANCIAL NEWS: Afferent taps crossover funds for $55M series C

    Afferent Pharmaceuticals Inc. (Boston, Mass.) raised $55 million in a series C round led by new investor Fidelity. New investors Jennison Associates; New Leaf Venture Partners; Partner Fund Management; Redmile Group; …

    Published on 7/8/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993